Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,135
in 3 filings

Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Abate Kristin −$2K Chief Accounting Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-17 Shacham Sharon Chief Scientific Officer Sale −9,088 $12.12 $110K 904,357
2022-02-17 Shacham Sharon Chief Scientific Officer Sale −9,079 $12.12 $110K 698,983
2022-02-17 Kauffman Michael Director Sale −9,079 $12.12 $110K 698,983
2022-02-17 Kauffman Michael Director Sale −9,088 $12.12 $110K 904,357
2022-02-07 Shah Jatin EVP, Chief Medical Officer Sale −1,704 $9.86 $17K 130,756
2022-02-07 Frenkel Ran EVP, Chief Dev. Officer Sale −1,991 $9.86 $20K 104,632
2022-02-07 Mason Michael EVP, CFO & Treasurer Sale −3,947 $9.86 $39K 53,308

Page 15 of 15 · 287 trades